OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology
Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, et al.
Journal of Biotechnology (2023) Vol. 379, pp. 98-119
Closed Access | Times Cited: 14
Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, et al.
Journal of Biotechnology (2023) Vol. 379, pp. 98-119
Closed Access | Times Cited: 14
Showing 14 citing articles:
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer
Katia Grillone, Giulio Caridà, Francesco Luciano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Katia Grillone, Giulio Caridà, Francesco Luciano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
What is the role of microbial biotechnology and genetic engineering in medicine?
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 11
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 11
The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 8
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 8
Progress on long non-coding RNAs in calcific aortic valve disease
Yan Shen, Jiahui Li, Zehao Zhao, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Yan Shen, Jiahui Li, Zehao Zhao, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Perspective Chapter: Decoding Cancer’s Silent Players – A Comprehensive Guide to LncRNAs
Abhijit Mandal, Sarbani Giri
IntechOpen eBooks (2025)
Open Access
Abhijit Mandal, Sarbani Giri
IntechOpen eBooks (2025)
Open Access
Molecular mechanisms of lncRNA NEAT1 in the pathogenesis of liver-related diseases, with special focus on therapeutic approaches
Ya‐Hui Wang, Gaurav Sanghvi, Suhas Ballal, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155867-155867
Closed Access
Ya‐Hui Wang, Gaurav Sanghvi, Suhas Ballal, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155867-155867
Closed Access
Non-coding RNA and drug resistance in head and neck cancer
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Advances in CRISPR-Cas systems for kidney diseases
Bhupendra Puri, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Progress in molecular biology and translational science (2024), pp. 149-162
Closed Access | Times Cited: 2
Bhupendra Puri, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Progress in molecular biology and translational science (2024), pp. 149-162
Closed Access | Times Cited: 2
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives
Majid Nazari, Emad Babakhanzadeh, Arghavan Mollazadeh, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Majid Nazari, Emad Babakhanzadeh, Arghavan Mollazadeh, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors
Bing Liao, Jialing Wang, Yalin Yuan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Bing Liao, Jialing Wang, Yalin Yuan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Comment on “CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer”
YuHan Wang, Yaling Li, Jun Li
Digestive and Liver Disease (2024) Vol. 56, Iss. 12, pp. 2170-2171
Closed Access
YuHan Wang, Yaling Li, Jun Li
Digestive and Liver Disease (2024) Vol. 56, Iss. 12, pp. 2170-2171
Closed Access
siRNA-based knockdown of lncRNAs; a new modality to target tumor progression
Abdulrahman Qais Khaleel, Saade Abdalkareem Jasim, Soumya V. Menon, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155746-155746
Closed Access
Abdulrahman Qais Khaleel, Saade Abdalkareem Jasim, Soumya V. Menon, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155746-155746
Closed Access
LncRNA MIAT binding to GATA3 activates MAPK signaling pathway and influences bronchopulmonary dysplasia
Siqiang Zheng, Erji Gao, Liang Guo, et al.
International Journal of Biological Macromolecules (2024), pp. 138280-138280
Closed Access
Siqiang Zheng, Erji Gao, Liang Guo, et al.
International Journal of Biological Macromolecules (2024), pp. 138280-138280
Closed Access
